Development of patient derived xenograft (PDX) models in human immune-reconstituted mice to evaluate efficacy of immunotherapeutic agents in lung and breast cancer

Izadi H.; Yan D.; Kato-Maves Y.; Thatte J.; Broudy T.

首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Development of patient derived xenograft (PDX) models in human immune-reconstituted mice to evaluate efficacy of immunotherapeutic agents in lung and breast cancer

【24h】

Development of patient derived xenograft (PDX) models in human immune-reconstituted mice to evaluate efficacy of immunotherapeutic agents in lung and breast cancer

机译：人免疫重构小鼠中患者衍生的异种移植物（PDX）模型，评价免疫治疗剂在肺癌和乳腺癌中的疗效

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2016年第null期|共2页
作者
Izadi H.; Yan D.; Kato-Maves Y.; Thatte J.; Broudy T.;
展开▼
作者单位

Crown Biosci San Diego CA USA;

Crown Biosci San Diego CA USA;

Crown Biosci San Diego CA USA;

Crown Biosci San Diego CA USA;

Crown Biosci San Diego CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Development of patient derived xenograft (PDX) models in human immune-reconstituted mice to evaluate efficacy of immunotherapeutic agents in lung and breast cancer [J] . Izadi H., Yan D., Kato-Maves Y., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：在人类免疫重建的小鼠中开发患者衍生的异种移植（PDX）模型以评估免疫治疗剂在肺癌和乳腺癌中的功效
2. Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model [J] . Weijing Cai, Ranjala Ratnayake, Michael H. Gerber, Investigational new drugs. . 2019,第2期

机译：αS10（APRA S10）作为抗胰腺癌剂的发展及其在原位患者衍生的异种移植物（PDX）模型中的初步评价
3. Establishment of patient-derived xenografts (PDX) models for triple negative breast cancer (TNBC) as a pre-clinical platform for drug development [J] . Thatte J., Meza M., Ricono J., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：建立三阴性乳腺癌（TNBC）的患者源异种移植（PDX）模型作为药物开发的临床前平台
4. Imaging patient derived breast cancer xenografts in an orthotopic mammary window chamber model [C] . Leung Hui Min, Schafer Rachel, Gmitro Arthur Conference on Lasers and Electro-Optics . 2015

机译：在原位乳腺窗腔模型中对患者衍生的乳腺癌异种移植物进行成像
5. Comparing gene expression profiles of cell culture models with profiles of tumor xenografts and patient tumors: Implications for lung and breast cancers. [D] . Creighton, Chad J. 2006

机译：将细胞培养模型的基因表达谱与异种移植瘤和患者肿瘤谱进行比较：对肺癌和乳腺癌的影响。
6. Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model [O] . Weijing Cai, Ranjala Ratnayake, Michael H. Gerber, 2018

机译：将Apratoxin S10（APRA S10）作为抗胰腺癌剂的发展及其在原位患者衍生的异种移植物（PDX）模型中的初步评价

Development of patient derived xenograft (PDX) models in human immune-reconstituted mice to evaluate efficacy of immunotherapeutic agents in lung and breast cancer

著录项

相似文献

相关主题

期刊订阅